Invesco Pharmaceuticals ETF (PJP) |
| 124.09 -0.646 (-0.52%) 09-11 15:59 |
| Open: | 125.88 |
| High: | 125.99 |
| Low: | 124.03 |
| Volume: | 26,402 |
| Market Cap: | 360(M) |
| PE Ratio: | 24.82 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 131.68 |
| Resistance 1: | 128.69 |
| Pivot price: | 128.19 |
| Support 1: | 123.85 |
| Support 2: | 103.04 |
| 52w High: | 131.68 |
| 52w Low: | 90.01 |
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 08 Sep 2026
Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits - The Motley Fool
Thu, 03 Sep 2026
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Fri, 28 Aug 2026
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? - The Motley Fool
Sun, 23 Aug 2026
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? - The Motley Fool
Wed, 19 Aug 2026
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - Yahoo Finance
Mon, 17 Aug 2026
XPH vs PJP: Which Pharma ETF Offers Better Value - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
